A detailed history of Glen Eagle Advisors, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 7,635 shares of ZTS stock, worth $1.26 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
7,635
Previous 7,792 2.01%
Holding current value
$1.26 Million
Previous $1.35 Billion 10.43%
% of portfolio
0.25%
Previous 0.25%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$172.58 - $196.48 $27,095 - $30,847
-157 Reduced 2.01%
7,635 $1.49 Billion
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $1.11 Million - $1.37 Million
7,642 Added 5094.67%
7,792 $1.35 Billion
Q1 2024

Jul 03, 2024

BUY
$165.67 - $199.94 $1.06 Million - $1.27 Million
6,370 New
6,370 $1.08 Billion
Q4 2023

Aug 13, 2024

BUY
$151.44 - $200.09 $608,940 - $804,561
4,021 Added 242.67%
5,678 $1.12 Billion
Q3 2023

Aug 13, 2024

BUY
$167.14 - $192.77 $67,691 - $78,071
405 Added 32.35%
1,657 $288 Million
Q2 2023

Aug 13, 2024

BUY
$160.94 - $186.23 $6,598 - $7,635
41 Added 3.39%
1,252 $216 Million
Q1 2023

Aug 13, 2024

BUY
$145.48 - $175.02 $6,401 - $7,700
44 Added 3.77%
1,211 $202 Million
Q4 2022

Aug 13, 2024

SELL
$131.14 - $157.47 $44,981 - $54,012
-343 Reduced 22.72%
1,167 $171 Million
Q3 2022

Aug 13, 2024

SELL
$148.29 - $182.55 $54,570 - $67,178
-368 Reduced 19.6%
1,510 $224 Million
Q2 2022

Aug 13, 2024

SELL
$155.97 - $200.09 $424,394 - $544,444
-2,721 Reduced 59.17%
1,878 $323 Million
Q1 2022

Aug 13, 2024

SELL
$181.39 - $234.03 $45,347 - $58,507
-250 Reduced 5.16%
4,599 $867 Million
Q4 2021

Aug 13, 2024

BUY
$193.69 - $247.03 $62,755 - $80,037
324 Added 7.16%
4,849 $1.18 Billion
Q3 2021

Aug 13, 2024

BUY
$189.29 - $209.69 $256,109 - $283,710
1,353 Added 42.65%
4,525 $879 Million
Q2 2021

Aug 13, 2024

BUY
$155.9 - $187.99 $135,944 - $163,927
872 Added 37.91%
3,172 $591 Million
Q1 2021

Aug 13, 2024

BUY
$144.0 - $169.39 $240,480 - $282,881
1,670 Added 265.08%
2,300 $375 Million
Q4 2020

Aug 13, 2024

SELL
$157.07 - $174.35 $901,581 - $1 Million
-5,740 Reduced 90.11%
630 $104 Million
Q3 2020

Aug 13, 2024

SELL
$137.1 - $165.37 $411 - $496
-3 Reduced 1.04%
285 $47.1 Million
Q1 2020

Aug 13, 2024

SELL
$92.66 - $144.94 $8,895 - $13,914
-96 Reduced 25.0%
288 $33.9 Million
Q4 2019

Aug 13, 2024

BUY
$116.25 - $133.25 $5,463 - $6,262
47 Added 13.95%
384 $50.8 Million
Q3 2019

Aug 13, 2024

BUY
$112.57 - $128.43 $6,416 - $7,320
57 Added 20.36%
337 $42 Million
Q2 2019

Aug 13, 2024

BUY
$97.98 - $114.28 $195 - $228
2 Added 0.72%
280 $31.8 Million
Q1 2019

Aug 13, 2024

SELL
$81.56 - $100.67 $496,863 - $613,281
-6,092 Reduced 95.64%
278 $28 Million
Q2 2018

Aug 13, 2024

BUY
$79.9 - $89.2 $10,387 - $11,596
130 Added 86.67%
280 $23.9 Million
Q1 2018

Aug 14, 2024

SELL
$71.51 - $84.69 $444,792 - $526,771
-6,220 Reduced 97.65%
150 $12.5 Million
Q3 2017

Aug 13, 2024

SELL
$59.73 - $65.4 $371,520 - $406,788
-6,220 Reduced 97.65%
150 $9.56 Million
Q4 2016

Aug 12, 2024

SELL
N/A
-6,220
150 $8.03 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.